Cognition Investment Portfolios

Cognition Therapeutics Spearheads Development in Treatments for Lewy Body Dementia Oct 2, 2024

Gain Therapeutics Reveals Promising Preclinical Data on GT-02287 for Parkinson's at FENS Forum 2024 May 30, 2024

Cognition Therapeutics Completes $11.5 Million Public Stock Sale Mar 15, 2024

Cognition Therapeutics CEO’s Letter Forecasts Key Milestones for Alzheimer's Disease Trial Jan 5, 2024